Kellerhals Carrard advised Vifor Pharma on the transaction. Vischer advised Inositec on the deal. Vifor Pharma acquired the Swiss firm Inositec AG, a clinical stage biopharmaceutical company…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
